Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 128
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 78
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 19
Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives
Wenzhao Liu, Zhanjun Ma, Yonggang Wang, et al.
Bioactive Materials (2022) Vol. 23, pp. 274-299
Open Access | Times Cited: 67
Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight
Syed Nasir Abbas Bukhari
Antioxidants (2022) Vol. 11, Iss. 3, pp. 554-554
Open Access | Times Cited: 47
Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Dur e Nayab, Fakhar ud Din, Hussain Ali, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer
Dhruv Sanjanwala, Vandana Patravale
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103550-103550
Closed Access | Times Cited: 22
Advances in Lipid Nanoparticle‐Based Disease Treatment
Yujie Zhou, Qiqi Ge, Xin Wang, et al.
ChemMedChem (2025)
Closed Access | Times Cited: 1
Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis
Li Li, Rendong He, Haili Yan, et al.
Nano Today (2022) Vol. 47, pp. 101654-101654
Closed Access | Times Cited: 36
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 19
Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases
Phuong‐Trang Nguyen‐Thi, Thuy Trang Nguyen, Hoàng Long Phan, et al.
Neurochemistry International (2023) Vol. 170, pp. 105612-105612
Closed Access | Times Cited: 18
Surface‐Functionalizable Plant‐Derived Extracellular Vesicles for Targeted Drug Delivery Carrier Using Grapefruit
Kyunghwan Moon, Jihyeon Hur, Kwang Pyo Kim, et al.
Advanced Materials Interfaces (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 13
Drug delivery for Alzheimer's disease using nanotechnology
Bindiya Chauhan, Shivani A. Patel, Bhupendra G. Prajapati, et al.
Elsevier eBooks (2024), pp. 361-371
Closed Access | Times Cited: 5
Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review
Anirban Goutam Mukherjee, Shatakshi Mishra, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102726-102726
Closed Access
Nano lipid-drug conjugates for the treatment of Alzheimer’s disease
Subhajit Mandal, Malay K. Das
Elsevier eBooks (2025), pp. 237-291
Closed Access
Recent progress in engineered extracellular vesicles and their biomedical applications
Farhan Mazahir, Awesh K. Yadav
Life Sciences (2024) Vol. 350, pp. 122747-122747
Closed Access | Times Cited: 4
PEGylated Polymer–Lipid Hybrid Nanoparticles to Enhance In Vivo Exposure and Uptake of Repaglinide in Brain Cells to Treat Diabetes-Linked Neurodegenerative Disorders
Geetika Wadhwa, Kowthavarapu Venkata Krishna, Sunil Kumar Dubey, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 5, pp. 3497-3512
Closed Access | Times Cited: 10
Diabetes Mellitus and Alzheimer’s Disease: Understanding Disease Mechanisms, their Correlation, and Promising Dual Activity of Selected Herbs
R. Pramanik, Anuradha Dey, Anirban Kr Chakrabarty, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118402-118402
Closed Access | Times Cited: 3
Exploring boron nitride nanotubes as potential drug delivery vehicles using density functional theory and molecular dynamics – An overview
Anjaly B. Krishna, Arjun Suvilal, Rakhesh Vamadevan, et al.
Journal of Molecular Liquids (2024), pp. 125968-125968
Closed Access | Times Cited: 3
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Thuy Trang Nguyen, Phuong‐Trang Nguyen‐Thi, Thi Hong Anh Nguyen, et al.
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 4, pp. 457-473
Closed Access | Times Cited: 8
Dissecting the interaction between Graphene Oxide and Human Transferrin via biophysical, biochemical and in-silico approaches: Implications for nanomaterial anti-fibrillation properties and protein structure.
Thaıs Meira Menezes, Marcos Gomes Ghislandi, Artur José da Silva, et al.
Journal of Molecular Liquids (2024) Vol. 410, pp. 125520-125520
Closed Access | Times Cited: 2
Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury–related Alzheimer's disease
Jie Jin, Huajing Zhang, Qianying Lu, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 9, pp. 2538-2555
Open Access | Times Cited: 2
Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation
Geetika Wadhwa, Kowthavarapu Venkata Krishna, Sunil Kumar Dubey, et al.
International Journal of Pharmaceutics (2023) Vol. 636, pp. 122824-122824
Closed Access | Times Cited: 6
Curcumin-loaded protein imprinted mesoporous nanosphere for inhibiting amyloid aggregation
Tongtong Hou, Nan Zhang, Chaoren Yan, et al.
International Journal of Biological Macromolecules (2022) Vol. 221, pp. 334-345
Closed Access | Times Cited: 10
Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy
Tong Yin, Yan Liu, Bin He, et al.
Materials Today Bio (2023) Vol. 22, pp. 100789-100789
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top